Elevated levels of LOX-1 are associated with endothelial dysfunction, inflammation, and oxidative stress, which are key factors in the progression of coronary artery disease (CAD) and adverse outcomes during CABG (21). The gene discussed is OLR1; the disease is coronary artery disorder.